You are here

Boston

With new CEO on board, Germany's Vibalogics lays out $150M for Boston viral vector site

With new CEO on board, Germany's Vibalogics lays out $150M for Boston viral vector site

Fierce Biotech

drug manufacturing

Flag link:

Takeda opens cell therapy manufacturing facility — tucked right in its Boston R&D hub

Takeda opens cell therapy manufacturing facility — tucked right in its Boston R&D hub

Endpoints

drug manufacturing

Flag link:

WuXi Biologics clinches deal to build first U.S. facility at Boston area hub

WuXi Biologics clinches deal to build first U.S. facility at Boston area hub

Fierce Pharma

Flag link:

One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis

One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis

Endpoints

immuno-oncology

Flag link:

Chiesi starts rare diseases division, ahead of potential Fabry disease filing

Chiesi starts rare diseases division, ahead of potential Fabry disease filing

Pharmaforum

Flag link:

$50M cell and viral vector manufacturing operation backed by Harvard

$50M cell and viral vector manufacturing operation backed by Harvard

Fierce Pharma

Flag link:

Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit

Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit

Fierce Pharma

Flag link:

The booming Boston/Cambridge biotech hub claims an industry-leading role — nobody beats it at raising record amounts of money

The booming Boston/Cambridge biotech hub claims an industry-leading role — nobody beats it at raising record amounts of money

Endpoints

Flag link:

Servier opens Kendall Square site, plans Chinese office to access external innovation

Servier opens Kendall Square site, plans Chinese office to access external innovation

Fierce Biotech

Flag link:

Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs

Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs

Endpoints

Flag link:

Bill And Melinda Gates Start A Nonprofit Biotech In Boston

Bill And Melinda Gates Start A Nonprofit Biotech In Boston

Forbes

Gates Foundation

drug development

Flag link:

Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push

Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push

Fierce Pharma

Amylyx Pharmaceuticals

Flag link:

Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report

Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report

Fierce Pharma

Flag link:

Pfizer preps new hires as it begins building a new, $200M R&D campus

Pfizer preps new hires as it begins building a new, $200M R&D campus

Endpoints

Flag link:

Why Biotech's Talent, Capital And Returns Are Consolidating Into Two Key Clusters

Why Biotech's Talent, Capital And Returns Are Consolidating Into Two Key Clusters

Forbes

Flag link:

R&D spending takes a back seat to other costs at Boston’s biggest biotechs

R&D spending takes a back seat to other costs at Boston’s biggest biotechs

Bizjournals.com

Flag link:

Big Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere

Big Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere

Bizjournals.com

Flag link:

Here are 13 MA cancer biotechs hoping to make waves next month

Here are 13 MA cancer biotechs hoping to make waves next month

Bizjournals.com

Ariad Pharmaceuticals

Vertex Pharmaceuticals

Infinity Pharmaceuticals

Foundation Medicine

Cerulean Pharma

Flag link:

Boston drug firm's shares slump due to job cuts, cash shortage

Boston drug firm's shares slump due to job cuts, cash shortage

Bizjournals.com

Flag link:

Pages